These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 27741115

  • 1. Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.
    Flahault A, Vignon M, Rabant M, Hummel A, Noël LH, Canioni D, Knebelmann B, Suarez F, El Karoui K.
    Medicine (Baltimore); 2016 Oct; 95(41):e5047. PubMed ID: 27741115
    [Abstract] [Full Text] [Related]

  • 2. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP, Kim DK, Oh DY, Paik JH, Moon KC, Kim S, Kim YS.
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [Abstract] [Full Text] [Related]

  • 3. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy.
    Cousin E, Flodrops H, Boyer O, Hogan J, Ruin M, Couderc A, Goujon JM, Taque S.
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27045. PubMed ID: 29603588
    [Abstract] [Full Text] [Related]

  • 4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q, Zhang Y, Zhou G, Zhu J.
    BMC Nephrol; 2020 Nov 23; 21(1):499. PubMed ID: 33225930
    [Abstract] [Full Text] [Related]

  • 5. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A, Gnemmi V, Lionet A, Renaud L, Gibier JB, Copin MC, Hachulla E, Hatron PY, Launay D, Fajgenbaum D, Terriou L.
    Front Immunol; 2019 Nov 23; 10():1489. PubMed ID: 31316523
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.
    J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386
    [Abstract] [Full Text] [Related]

  • 15. Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.
    Tosaki T, Okabe M, Suzuki T, Shimizu A, Koike K, Tsuboi N, Kawamura T, Ohashi R, Yano S, Yokoo T.
    CEN Case Rep; 2021 May 14; 10(2):265-272. PubMed ID: 33389670
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.
    Sugawara E, Sato T, Amasaki Y, Katsumata K.
    Medicine (Baltimore); 2022 Feb 25; 101(8):e28941. PubMed ID: 35212301
    [Abstract] [Full Text] [Related]

  • 18. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Hoshino J, Sawa N, Fujii T, Takaichi K, Ohashi K, Ubara Y.
    Hum Pathol; 2018 Dec 25; 82():258-263. PubMed ID: 29626596
    [Abstract] [Full Text] [Related]

  • 19. Rapid Clinical Improvement of Multicentric Castleman Disease (MCD) with Renal Involvement Following Treatment with Tocilizumab: AA Amyloidosis as a Possible Renal Involvement of MCD.
    Temmoku J, Sasajima T, Kuroda T, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Fujita Y, Matsuoka N, Asano T, Sato S, Yamada T, Hashimoto Y, Migita K.
    Tohoku J Exp Med; 2023 Mar 15; 259(4):285-291. PubMed ID: 36653160
    [Abstract] [Full Text] [Related]

  • 20. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
    Nunes MB, Rotman S, Duss FR, Halfon M.
    BMJ Case Rep; 2020 Jan 06; 13(1):. PubMed ID: 31911409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.